Finance

Lists
Outlook: 18.8% bullish·43.8% bearish
Go to analysis
STZ:NYSE
Constellation Brands Inc
$116.57
-0.87%
(-1.02) 1D
$116.57
0.00% (0.00)
After hours
Closed: Sep 23, 4:00:04 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STZ...
Open
$117.10
High
$118.00
Low
$115.50
Mkt. cap
19.91B
Avg. vol.
2.16M
Volume
0.00
Dividend
3.53%
Quarterly dividend
$1.03
Ex-dividend date
Jul 30, 2026
P/E ratio
11.12
52-wk high
$168.60
52-wk low
$115.50
EPS
$10.48
Beta
0.41
Shares outstanding
170.75M
No. of employees
9K
Open
$117.10
High
$118.00
Low
$115.50
Mkt. cap
19.91B
Avg. vol.
2.16M
Volume
0.00
Dividend
3.53%
Quarterly dividend
$1.03
Ex-dividend date
Jul 30, 2026
P/E ratio
11.12
52-wk high
$168.60
52-wk low
$115.50
EPS
$10.48
Beta
0.41
Shares outstanding
170.75M
No. of employees
9K
News stories
From web sources and news partners
Profile
Constellation Brands, Inc. is an American producer and marketer of beer, wine, and spirits. A Fortune 500 company, Constellation is the largest beer import company in the US, measured by sales, and has the third-largest market share of all major beer suppliers. It also has sizable investments in medical and recreational cannabis through its association with Canopy Growth. Based in Rochester, New York, Constellation has about 40 facilities and approximately 9,000 employees. The company has more than 27 brands in its portfolio. Wine brands include Robert Mondavi, Kim Crawford, Ruffino, and The Prisoner Wine Company. Constellation's beer portfolio includes imported brands such as rights in the United States to Corona, Modelo Especial, Negra Modelo, and PacĂ­fico. Spirits brands include Casa Noble Tequila, High West Whiskey, and Nelson's Green Brier Tennessee Whiskey. Wikipedia
About Constellation Brands Inc
CEONicholas Fink
Employees9.4K
Founded1945
HeadquartersVictor (village), New York, New York, United States
SectorDistillery
Websitecbrands.com
Analyst ratings
Based on 18 analysts giving stock ratings to STZ in the past 3 months
Buy
Buy
11
Hold
6
Sell
1
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for STZ in the last 3 months.
Highest
Current $116.57
$209.00 (+79.29%)
Average
$165.59 (+42.05%)
Lowest
$122.00 (+4.66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Peter Grom
UBS
Buy
Maintained
$145.00
+24.4%
09/23/2026
Lauren Lieberman
Barclays
Hold
Maintained
$122.00
+4.7%
09/22/2026
Filippo Falorni
Citi
Buy
Maintained
$165.00
+41.5%
09/23/2026
Robert Ottenstein
Evercore ISI
Buy
Maintained
$160.00
+37.3%
09/21/2026
Dara Mohsenian
Morgan Stanley
Hold
Reiterated
$158.00
+35.5%
09/18/2026
Peter Galbo
Bank of America Securities
Sell
Maintained
$145.00
+24.4%
09/18/2026
Seamus Cassidy
TD Cowen
Buy
Reiterated
$150.00
+28.7%
09/17/2026
Nadine Sarwat
Bernstein
Buy
Maintained
$197.00
+69%
09/15/2026
Stephen Powers
Deutsche Bank
Hold
Reiterated
$136.00
+16.7%
09/11/2026
Bonnie Herzog
Goldman Sachs
Buy
Reiterated
-
-
07/22/2026
Drew Levine
J.P. Morgan
Hold
Maintained
$165.00
+41.5%
07/02/2026
Gerald Pascarelli
Needham
Buy
Reiterated
$185.00
+58.7%
07/02/2026
Nik Modi
RBC Capital
Buy
Maintained
$185.00
+58.7%
07/02/2026
Andrew Strelzik
BMO Capital
Buy
Reiterated
$190.00
+63%
07/02/2026
Christopher Carey
Wells Fargo
Buy
Reiterated
$170.00
+45.8%
07/02/2026
Georgy Vashchenko
Freedom Capital Markets
Hold
Downgraded
$173.00
+48.4%
07/01/2026
Bill Kirk
Roth MKM
Buy
Reiterated
$209.00
+79.3%
07/02/2026
Michael Lavery
Piper Sandler
Hold
Maintained
$160.00
+37.3%
07/01/2026
Robert Moskow
TD Cowen
Buy
Maintained
$174.00
+49.3%
06/30/2026
Kaumil Gajrawala
Jefferies
Hold
Maintained
$157.00
+34.7%
06/23/2026
Christian Junquera
Bank of America Securities
Sell
Maintained
$154.00
+32.1%
04/15/2026
Next call in 13 days
Wed, Oct 7, 8:00 AM
Fiscal period
Q2 2027
EPS / Est. (USD)
- / $3.55
Revenue / Est. (USD)
- / 2.54B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
2.48B
2.22B
1.92B
2.43B
Cost of goods sold
1.17B
1.04B
964.20M
1.11B
Cost of revenue
1.17B
1.04B
964.20M
1.11B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
408.60M
430.60M
443.60M
448.10M
Operating expense
408.60M
430.60M
443.60M
448.10M
Total operating expenses
1.58B
1.47B
1.41B
1.56B
Operating income
903.40M
753.90M
512.40M
874.10M
Other non operating income
-8.30M
-8.10M
-12.10M
-5.10M
EBT including unusual items
782.90M
632.30M
351.20M
760.00M
EBT excluding unusual items
805.00M
686.50M
415.40M
784.00M
Income tax expense
296.80M
110.10M
126.50M
88.10M
Effective tax rate
37.91%
17.41%
36.02%
11.59%
Other operating expenses
-
-
-
-
Net income
466.00M
502.80M
201.80M
653.80M
Net profit margin
18.78%
22.62%
10.51%
26.88%
Earnings per share
3.63
3.06
1.90
3.43
Interest and investment income
2.40M
3.80M
2.50M
2.20M
Interest expense
-89.00M
-86.60M
-85.40M
-87.70M
Net interest expenses
-86.60M
-82.80M
-82.90M
-85.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.01B
852.90M
625.50M
971.70M
Gain or loss from assets sale
-52.10M
31.90M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps